GLAXOSMITHKLINE INTERNATIONAL LIMITED

02298366
Active United Kingdom

Other business support service activities n.e.c.

0 employees website.com
Other business support service activities n.e.c.
G

GLAXOSMITHKLINE INTERNATIONAL LIMITED

02298366

Other business support service activities n.e.c.

Founded 21 Sept 1988 Active United Kingdom 0 employees website.com
Other business support service activities n.e.c.

Previous Company Names

SMITHKLINE BEECHAM INTERNATIONAL LIMITED 6 Sept 1989 — 27 Oct 2004
SMITHKLINE BECKMAN INTERNATIONAL LIMITED 21 Oct 1988 — 6 Sept 1989
Accounts Submitted 22 Jun 2026 Next due 30 Sept 2026 3 months remaining
Confirmation Submitted 8 Sept 2025 Next due 22 Sept 2026 2 months remaining
Net assets £1,577M £47M 2024 year on year
Total assets £1,805M £68M 2024 year on year
Total Liabilities £228M £21M 2024 year on year
Charges None No charges registered

Contact & Details

Contact

Full company profile for GLAXOSMITHKLINE INTERNATIONAL LIMITED (02298366), an active company based in United Kingdom. Incorporated 21 Sept 1988. Other business support service activities n.e.c.. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type audit-exemption-subsidiary
Next accounts 31 Dec 2025
Due by 30 Sept 2026 3 months remaining

Net Assets, Total Assets & Total Liabilities (2014–2024)

Cash in Bank

N/A

Net Assets

£1577.00M

Increased by £46.81M (+3%)

Total Liabilities

£227.79M

Increased by £21.39M (+10%)

Turnover

N/A

Employees

N/A

Debt Ratio

13%

Increased by 1 (+8%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
31 Dec Year End
2023
31 Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

Officers

0 active 3 resigned
Status

No officers found

No officers found

Shareholders

Shareholders (1)

Glaxosmithkline Biologicals
100.0%

Persons with Significant Control

Persons with Significant Control (1)

1 Active

Setfirst Limited

United Kingdom

Active
Notified 6 Apr 2016
Nature of Control
  • Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent,right To Appoint And Remove Directors

Group Structure

Group Structure

GSK PLC united kingdom
SETFIRST LIMITED united kingdom
GLAXOSMITHKLINE INTERNATIONAL LIMITED Current Company

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
22 Jun 2026AccountsAnnual accounts made up to 31 Dec 2025
22 Jun 2026OtherAudit exemption statement of guarantee by parent company for period ending 31/12/25
22 Jun 2026OtherNotice of agreement to exemption from audit of accounts for period ending 31/12/25
22 Jun 2026AccountsAnnual accounts filed
22 Jun 2026OtherAudit exemption statement of guarantee by parent company for period ending 31/12/25
22 Jun 2026 Accounts

Annual accounts made up to 31 Dec 2025

22 Jun 2026 Other

Audit exemption statement of guarantee by parent company for period ending 31/12/25

22 Jun 2026 Other

Notice of agreement to exemption from audit of accounts for period ending 31/12/25

22 Jun 2026 Accounts

Annual accounts filed

22 Jun 2026 Other

Audit exemption statement of guarantee by parent company for period ending 31/12/25

Recent Activity

Latest Activity

Annual accounts made up to 31 Dec 2025

5 days ago on 22 Jun 2026

Audit exemption statement of guarantee by parent company for period ending 31/12/25

5 days ago on 22 Jun 2026

Notice of agreement to exemption from audit of accounts for period ending 31/12/25

5 days ago on 22 Jun 2026

Annual accounts filed

5 days ago on 22 Jun 2026

Audit exemption statement of guarantee by parent company for period ending 31/12/25

5 days ago on 22 Jun 2026